Exposure to improved nutrition from conception to age 2 years and adult cardiometabolic disease risk: a modelling study
- PMID: 30012268
- PMCID: PMC6138451
- DOI: 10.1016/S2214-109X(18)30231-6
Exposure to improved nutrition from conception to age 2 years and adult cardiometabolic disease risk: a modelling study
Erratum in
-
Correction to: Exposure to improved nutrition from conception to age 2 years and adult cardiometabolic disease risk: misclassification of 31 individuals.Lancet Glob Health. 2020 Jan;8(1):e37. doi: 10.1016/S2214-109X(19)30466-8. Lancet Glob Health. 2020. PMID: 31839139 No abstract available.
-
Correction to Lancet Glob Health 2018; 6: e875-84.Lancet Glob Health. 2020 Jan;8(1):e38. doi: 10.1016/S2214-109X(19)30501-7. Lancet Glob Health. 2020. PMID: 31839140 Free PMC article. No abstract available.
Abstract
Background: Low-income and middle-income countries with populations that are chronically undernourished in early life are undergoing a nutrition transition and are experiencing an epidemic of cardiometabolic disease. These dual burdens are thought to be causally related; therefore, the extent to which improvements in early-life nutrition can offset adult-onset disease is important. The aim of this study was to examine whether improvement of protein-energy nutrition from conception to age 2 years can attenuate the risk of cardiometabolic disease.
Methods: We followed up a cohort of 2392 individuals born between Jan 1, 1962, and Feb 28, 1977, in four villages in Guatemala who had participated in a cluster-randomised protein-energy nutritional supplementation (Atole) trial. Of 1661 participants available for follow-up from Feb 26, 2015, to April 29, 2017, we studied 684 women and 455 men. We assessed cardiometabolic disease risk at ages 37-54 years using anthropometry, fasting and post-challenge glucose, fasting lipid concentrations, and blood pressure. We used generalised linear and logistic regression modelling to estimate the effect of Atole from conception to age 2 years (the first 1000 days) on cardiometabolic disease risk.
Findings: Exposure to Atole from conception to age 2 years was associated with increased fatness (body-mass index [1·29 kg/m2, 95% CI 0·08 to 2·50], body fat [1·73%, 0·20 to 3·26], and obesity [odds ratio 1·94, 1·11 to 3·40]), diastolic blood pressure (1·59 mm Hg, -0·74 to 3·92), and blood lipids (total cholesterol [10·10 mg/dL, 0·80 to 19·40] and non-HDL cholesterol [10·41 mg/dL, 1·51 to 19·31]), reduced post-challenge glucose (-5·84 mg/dL, -12·51 to 0·83), and reduced odds of diabetes (odds ratio 0·46, 0·21 to 0·97). We found stratum heterogeneity by sex in pooled models for non-HDL cholesterol (4·34 mg/dL, 95% CI -6·86 to 15·55 for women vs 19·84 mg/dL, 5·86 to 33·82 for men) and post-challenge glucose (-0·19 mg/dL, -8·63 to 8·24 for women vs -13·10 mg/dL, -23·64 to -2·56 for men). p values for interaction of sex and exposure to Atole from conception to age 2 years were 0·09 and 0·04, respectively.
Interpretation: Improved protein-energy nutrition from conception to the 2nd birthday reduced the odds of diabetes at ages 37-54 years; however, this protein-energy supplementation also increased the risk of obesity and several obesity-related conditions. Our findings suggest a mixed ability of protein-energy nutritional supplementation in early life to prevent adult cardiometabolic disease incidence in the context of high childhood stunting and high adult overweight and obesity.
Funding: National Institutes of Health.
Copyright © 2018 The Author(s). Published by Elsevier Ltd. This is an Open Access article under the CC BY-NC-ND 4.0 license. Published by Elsevier Ltd.. All rights reserved.
Conflict of interest statement
Declaration of interests
ADS reports grants from US National Institutes of Health during the conduct of the study. All other authors declare no competing interests.
Figures
Comment in
-
Early life nutritional supplements and later metabolic disease.Lancet Glob Health. 2018 Aug;6(8):e816-e817. doi: 10.1016/S2214-109X(18)30308-5. Lancet Glob Health. 2018. PMID: 30012254 No abstract available.
References
-
- Victora CG, de Onis M, Hallal PC, Blössner M, Shrimpton R. Worldwide timing of growth faltering: revisiting implications for interventions. Pediatrics 2010; 125: e473–80. - PubMed
-
- Barker DJP. Fetal programming of coronary heart disease. Trends Endocrinol Metab 2002; 13: 364–68. - PubMed
-
- Corvalán C, Gregory CO, Ramirez-Zea M, Martorell R, Stein AD. Size at birth, infant, early and later childhood growth and adult body composition: a prospective study in a stunted population. Int J Epidemiol 2007; 36: 550–57. - PubMed
-
- Adair LS. Size at birth and growth trajectories to young adulthood. Am J Hum Biol Off J Hum Biol Counc 2007; 19: 327–37. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous